These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 28062551)

  • 1. New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF.
    Massin N
    Hum Reprod Update; 2017 Mar; 23(2):211-220. PubMed ID: 28062551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medroxyprogesteron acetate use to block LH surge in oocyte donor stimulation].
    Crha I; Ventruba P; Filipinská E; Dziakova M; Žáková J; Ješeta M; Lousová E; Papíková Z
    Ceska Gynekol; 2018; 83(1):11-16. PubMed ID: 29510633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?
    La Marca A; Capuzzo M
    Reprod Biomed Online; 2019 Aug; 39(2):321-331. PubMed ID: 31138494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle.
    Cimadomo D; Vaiarelli A; Colamaria S; Trabucco E; Alviggi C; Venturella R; Alviggi E; Carmelo R; Rienzi L; Ubaldi FM
    Hum Reprod; 2018 Aug; 33(8):1442-1448. PubMed ID: 29912374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
    Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IVF characteristics and the molecular luteal features of random start IVF cycles are not different from conventional cycles in cancer patients.
    Esmaeilian Y; Hela F; Bildik G; Akin N; İltumur E; Yusufoglu S; Yildiz CS; Keles İ; Vatansever D; Taskiran C; Yakin K; Oktem O
    Hum Reprod; 2023 Jan; 38(1):113-124. PubMed ID: 36367834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late Follicular Phase Ovarian Stimulation Without Exogenous Pituitary Modulators.
    Zhu X; Ye J; Fu Y
    Front Endocrinol (Lausanne); 2020; 11():487. PubMed ID: 32903567
    [No Abstract]   [Full Text] [Related]  

  • 9. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How effective are the non-conventional ovarian stimulation protocols in ART? A systematic review and meta-analysis.
    Glujovsky D; Pesce R; Miguens M; Sueldo CE; Lattes K; Ciapponi A
    J Assist Reprod Genet; 2020 Dec; 37(12):2913-2928. PubMed ID: 33219862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders.
    Chen Q; Wang Y; Sun L; Zhang S; Chai W; Hong Q; Long H; Wang L; Lyu Q; Kuang Y
    Reprod Biol Endocrinol; 2017 Sep; 15(1):71. PubMed ID: 28870217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol).
    Kuang Y; Chen Q; Hong Q; Lyu Q; Ai A; Fu Y; Shoham Z
    Reprod Biomed Online; 2014 Dec; 29(6):684-91. PubMed ID: 25444501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation.
    La Marca A; Capuzzo M; Sacchi S; Imbrogno MG; Spinella F; Varricchio MT; Minasi MG; Greco P; Fiorentino F; Greco E
    Hum Reprod; 2020 Jun; 35(6):1325-1331. PubMed ID: 32395749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
    Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
    Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous progesterone for LH surge prevention is redundant in ovarian stimulation protocols.
    Messinis IE; Messini CI; Anifandis G; Daponte A
    Reprod Biomed Online; 2021 Apr; 42(4):694-697. PubMed ID: 33583700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteal Phase Ovarian Stimulation versus Follicular Phase Ovarian Stimulation results in different Human Cumulus cell genes expression: A pilot study.
    Chen YC; Li JY; Li CJ; Tsui KH; Wang PH; Wen ZH; Lin LT
    Int J Med Sci; 2021; 18(7):1600-1608. PubMed ID: 33746576
    [No Abstract]   [Full Text] [Related]  

  • 17. The best execution of the DuoStim strategy (double stimulation in the follicular and luteal phase of the same ovarian cycle) in patients who are poor ovarian responders.
    Luo Y; Sun L; Dong M; Zhang X; Huang L; Zhu X; Nong Y; Liu F
    Reprod Biol Endocrinol; 2020 Oct; 18(1):102. PubMed ID: 33059712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexible ovarian stimulation in a poor responder: a case report and literature review.
    Xu B; Li Y
    Reprod Biomed Online; 2013 Apr; 26(4):378-83. PubMed ID: 23497915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.